自助式与临床医生引导的在线认知行为疗法治疗特应性皮炎:一项随机临床试验
这项单盲随机非劣效性试验在瑞典招募168名成人特应性皮炎患者,比较12周自助式与医生引导在线认知行为疗法。主要结局POEM评分变化显示自助组非劣效于医生引导组,且自助组所需临床资源更少。
要点
- 自助在线CBT在改善AD症状严重度方面非劣效于医生引导CBT。
- 自助CBT仅需评估时间,显著减少临床医生投入。
- 两组均未报告严重不良事件,自助CBT可作为扩大治疗覆盖的可行方式。
核心结论
- 简版在线自助CBT在降低AD患者POEM评分方面非劣效于综合在线医生引导CBT。
主要发现
- 干预后医生引导组POEM改善4.20分(95%CI 1.94-6.05),自助组改善4.60分(95%CI 2.57-6.64)。
- 估计组间变化均值差为0.36分(单侧97.5%CI,-∞至1.75),低于预设非劣效界值3分。
- 医生引导组临床医生平均花费36.0分钟(SD 33.3,95%CI 29.2-41.7)进行治疗指导,评估平均花费14.0分钟(SD 6.0,95%CI 12.9-15.6);自助组评估平均花费15.8分钟(SD 6.4)。
- 未报告严重不良事件。
关键数值与推荐
- 主要结局为自报POEM评分从基线至干预后12周随访的变化,预设非劣效界值为POEM 3分。
- 非劣效性判定:均值差0.36分的单侧97.5%CI上限1.75分小于3分界值。
临床怎么用
- 自助在线CBT所需临床资源有限,可作为循证心理治疗在AD患者中推广的可行手段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Clinician-guided online self-help based on cognitive behavioral therapy (CBT) has been shown to be effective at decreasing symptom severity for people with atopic dermatitis (AD). A brief online self-guided CBT intervention could be more cost-effective and allow for easy implementation and broader outreach compared with more comprehensive clinician-guided interventions. OBJECTIVE: To investigate whether a brief online self-guided CBT intervention is noninferior to a comprehensive online clinician-guided CBT treatment. DESIGN, SETTING, AND PARTICIPANTS: This single-blind randomized clinical noninferiority trial was conducted at Karolinska Institutet, Stockholm, Sweden. Adult individuals with AD were enrolled from November 2022 to April 2023. The last postintervention data were collected in December 2023. INTERVENTIONS: Participants randomized to the self-guided group had access to a self-guided online CBT intervention for 12 weeks without clinician support. Participants randomized to the clinician-guided group received online CBT for 12 weeks. MAIN OUTCOMES AND MEASURES: The primary outcome was change in score from baseline to postintervention to 12-week follow-up on the self-reported Patient-Oriented Eczema Measure (POEM). The predefined noninferiority margin was 3 points on POEM. RESULTS: Of 168 randomized participants, 142 (84.5%) were female, and the mean (SD) age was 39 (10.5) years. A total of 86 participants were randomized to the self-guided group and 82 were randomized to the clinician-guided group. A total of 151 (90.0%) completed the main outcome postintervention assessment. Postintervention, the clinician-guided group had improved 4.20 points (95% CI, 1.94-6.05) on POEM and the self-guided group improved 4.60 points (95% CI, 2.57-6.64), corresponding to an estimated mean difference in change of 0.36 points (1-sided 97.5% CI, -∞ to 1.75), which was below the noninferiority margin of 3 points. No serious adverse events were reported. In the clinician-guided group, clinicians spent a mean (SD) of 36.0 (33.3) minutes (95% CI, 29.2-41.7) on treatment guidance and 14.0 (6.0) minutes (95% CI, 12.9-15.6) on assessments compared to 15.8 (6.4) minutes on assessments in the self-guided group. CONCLUSIONS AND RELEVANCE: In this randomized clinical noninferiority trial, a brief self-guided CBT intervention was noninferior to clinician-guided CBT. Given the limited clinical resources required to deliver self-guided CBT, this treatment might be a promising means to disseminate evidence-based psychological treatment for patients with AD. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05517850.
引用
- Kern D, Ljótsson B, Lönndahl L, et al. Self-Guided vs Clinician-Guided Online Cognitive Behavioral Therapy for Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2025. PMID: 39693097. doi:10.1001/jamadermatol.2024.5044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。